I am seeing a clear break of structure with a large liquidity gap above at my red lines.
With benefits to pharma tariffs being lifted it will provide bullish narratives for exporting our pharma production.
I honestly don't know much about the stock, but the technicals add up here.
Bearish thesis is a gap down to grab liquidity for long term.
With benefits to pharma tariffs being lifted it will provide bullish narratives for exporting our pharma production.
I honestly don't know much about the stock, but the technicals add up here.
Bearish thesis is a gap down to grab liquidity for long term.
Order cancelled
hahahahahahahhaha oh my goodnessNote
Might be a solid buy here. Sad to say but could play outDisclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.